Much research has focused on the responses to microbial products of immune cells such as monocytes, macrophages, and neutrophils. Although the liver is a primary response organ in various infections, relatively little is known about the antimicrobial responses of its major cell type, the hepatocyte. It is now known that the recognition of bacteria occurs via cell-surface proteins that are members of the Toll-like receptor (TLR) family. In addition, lipopolysaccharide (LPS) is bound by circulating LPS-binding protein (LBP) and presented to cell-surface CD14, which in turn interacts with TLR and transduces an intracellular signal. We investigated the CD14 and TLR2 responses of whole liver and isolated hepatocytes, and demonstrated that these cells can be induced to express the molecules necessary for responses to both Gram-positive and Gram-negative bacteria. Our findings may have clinical implications for pathological states such as sepsis.
INTRODUCTION

Sepsis and microbial recognition
Sepsis following trauma or major surgery results in prolonged, expensive intensive care unit hospitalization and remains a major cause of mortality. It is estimated that approximately 750,000 patients develop sepsis, of whom 215,000 die. 1 Sepsis is most often caused by bacterial infection, and even more specifically by Gram-negative bacterial infection, 1 although Gram-positive bacterial sepsis is also a serious clinical problem with distinct features. 2 The host recognizes the presence of bacterial infections through multiple mechanisms, involving both elements of the adaptive immune response (e.g. antibodies and complement; T-cell responses to bacterial superantigens) as well as elements of the innate immune response, the focus of this article. The innate immune response has evolved to recognized so-called 'molecular patterns' on microbes, rather than the antigenically distinct structural elements recognized by antibodies or by T-cell receptors in the context of major histocompatibility molecules. 3 On Gram-negative bacteria, the main stimulant of the innate immune response is endotoxin (lipopolysaccharide; LPS), whereas mammalian hosts recognize a diverse group of Gram-positive bacterial macromolecules including lipoarabinomannan (LAM), peptidoglycan (PGN), and lipoteichoic acid (LTA). Other bacterial 'molecular patterns' include N-formyl methionylated peptides 4 and CpG DNA. 5 As described in detail below, this bacterial recognition system relies on cell surface receptors that are highly conserved throughout evolution, members of the Toll-like receptor family. 3, 6 Following stimulation of these receptors, the host elaborates numerous pro-inflammatory cytokines (tumor necrosis factor-α [TNF-α], interleukin-1 [IL-1], IL-6, and IL-8 predominate). In turn, these cytokines result in the production of powerful effector mechanisms, including the free radicals superoxide and nitric oxide (NO) (Fig. 1) . 7, 8 These mechanisms are clearly necessary for the host to mount an effective antimicrobial defense; however, the inflammatory consequences of a severe infection often cause great harm to the host, including hypotension, tissue and organ damage, and death. 1, [7] [8] [9] In no organ are these interactions more important than in the liver.
The role of the liver in the response to infection
It is clear that the presence of bacterial infection, detected by the host through numerous intersecting pathways, elicits a vigorous response in multiple organs and circulating cells. 8, 9 It is also clear, however, that the liver is the primary site of response and microbial clearance following bacterial infection. [7] [8] [9] [10] [11] Up to 80% of injected LPS concentrates in the liver within 20-30 min, 10 and within hours, LPS can be found in the bile. 12 Lipopolysaccharide clearly interacts with Kupffer cells and endothelial cells, 10, 13, 14 which may serve to process LPS so that it can be taken up more efficiently by hepatocytes (HC). 14, 15 However, LPS can be found in HC just 5 min following an intraportal injection of endotoxin. 16 It has been estimated that up to 75% of LPS is directly cleared by HC and not nonparenchymal cells such as Kupffer cells. 17 Much of the uptake must occur through the interaction of LPS first with proteins, lipoproteins, or chylomicrons, 18 but the role of CD14, perhaps the most efficient LPS transfer molecule known, has not been studied. Studies in macrophages and Chinese hamster ovary (CHO) cells transfected with CD14 (CHO/CD14) cells indicate that CD14 participates in the internalization/degradation of LPS and that up to 90% of the LPS-LBP complexes that bind to a cell via CD14 are internalized and do not participate in cellular activation. 19 Another primary function of the liver in sepsis is the production of acute-phase proteins (APP), defined as proteins that increase or decrease in the plasma by at least 25% following trauma or infection. Positive APP (those whose concentration increases) include fibrinogen, C reactive protein, and α 2 -macroglobulin, while negative APP include albumin and retinal binding protein. 20 As described below, soluble CD14 (sCD14) can also be considered an APP, since it increases in humans by up to 75% during sepsis. [21] [22] [23] Another soluble LPS recognition molecule, LPS binding protein (LBP), is also now considered a positive APP. 24 Our previously published studies have demonstrated clearly the crucial role of the liver as well as of HC in the production of CD14 and LBP. 25, 26 A further important role of the liver in sepsis is the elaboration of pro-inflammatory cytokines such as (TNF-α and IL-1, produced by Kupffer cells in the liver. 7, 8, 27, 28 HC respond to these cytokines in numerous ways, including induction of nitric oxide synthase (iNOS; NOS2). 7, 8 We have demonstrated that HC increase the expression of CD14, which presents LPS to TLR4. 6 HC also increase the expression of Toll-like receptor-2 (TLR2), a cell surface protein that mediates the effects of Gram-positive bacterial products as well as, in some settings, LPS. 6 
Hepatocytes and Kupffer cells respond to bacterial products
Recent years have seen resurgence of interest in the innate immune response to pathogens, and this is of great practical interest in the treatment of postoperative sepsis. The majority of attention has been focused on the role of neutrophils as well as monocytes and monocytederived macrophages in the recognition and response to bacteria. The response to bacterial products has received a special focus, and has led to the elucidation of the socalled pattern recognition receptor system. 3 We have focused on the role of the liver in the response to microbial infections, and have identified several components of the response to microbial products such as Gram-negative LPS in HC. A large body of literature demonstrates that the liver is clearly able to respond to the products of both Gram-positive and Gram-negative bacteria, although little has been published previously about the responses of isolated HC and Kupffer cells to Gram-positive bacterial products (Table 1) .
Our goal has been to elucidate the mechanisms by which LPS might modulate the liver in vivo or hepatocytes in vitro. Our data 25 and that of others 29 have indicated that hepatocytes express CD14 under basal conditions, and hepatic CD14 mRNA and protein levels are markedly increased during endotoxemia. Furthermore, this expression is controlled at the level of transcription. 25, 26 We have proposed that hepatocytes contribute to both the basal systemic levels of soluble CD14 as well as the up-regulation of CD14 that occurs during the acute-phase response. Resting hepatocytes express surface CD14 and release soluble CD14 in vitro, and hepatic CD14 expression is dramatically up-regulated by LPS in vivo. 25 Recent data have also shown that human liver cells have the highest basal level of CD14 expression, followed by the lung and the placenta. 30 In addition to CD14, several Toll-like receptors (TLRs) have been identified as transmembrane co-receptors for CD14 in the cellular response to LPS and other bacterial products ( Fig. 2) . 3, 6 This family of proteins, the mammalian homologues of the Drosophila protein, Toll, contain intracellular motifs that are highly homologous to intracellular signaling domains of IL-1 receptor type I (IL-1RI). So far, at least 10 members of this family (TLR1-10) have been discovered, but only TLR2 and TLR4 have been implicated in the signaling of LPS. Recent studies suggest that a defective murine TLR4 is responsible for the LPShyporesponsiveness in two mouse strains (C3H/HeJ and C57BL10/ScCr). Furthermore, TLR4-deficient mouse studies indicate that TLR4 is essential in LPS signaling. In contrast, TLR2 is not sufficient to confer LPS responsiveness. Instead, accumulating evidence indicates that TLR2 is a signaling molecule for a variety of Gram-positive bacterial Hepatocytes and microbial products 367 
Fig. 2
Molecular recognition and response to microbial products through pattern recognition receptors. Following binding of LPS or Gram-positive bacterial products to LBP and subsequently to CD14, the complex signals intracellularly through Toll-like receptor 4 (TLR4) or TLR2, respectively. Following dimerization of the TLR, these domains attract the adaptor protein MyD88, which in turn recruits the protein tyrosine kinase IRAK. In turn, IRAK phosphorylates TRAF6, which in turn attracts two more protein tyrosine kinases, TAB1 and TAK1. These kinases then go on to activate the transcription factors AP-1 and NF-κB.
products such as Gram-positive lipoproteins, LTA, PGN, and mycobacterial LAM, with a role in mediating macrophage and epithelial cell activation. 3, 6 As we discuss below, we have found that cytokines up-regulate TLR2 on hepatocytes, 31 and suggest that this may have implications for the function of hepatocytes in sepsis.
LPS activates cells through the MAP kinase pathway
The mitogen-activated protein (MAP) kinases are a group of related serine/threonine protein kinases that participate in transmitting extracellular signals to the cell nucleus. Activation of each of the three major MAP kinase subfamilies (ERK1/2, JNK1/2 and p38) involves dual phosphorylation of tyrosine and threonine residues within the catalytic domain of these enzymes. 32 Different stimuli are known to activate one or more of these MAP kinase subfamily pathways. Various mitogens and differentiative stimuli are able to activate the ERK cascade, 33 while cellular stress and pro-inflammatory cytokines are the primary activators of the JNK and p38 pathways. 34, 35 However, all three subgroups have been implicated in inflammatory processes. LPS-stimulated MAP kinase activation has predominantly been studied in monocytes and macrophages, with no current information regarding their role in LPS-stimulated HC. Interestingly, LPS strongly stimulates all three of these MAP kinase pathways in both macrophages and monocytes, [36] [37] [38] although the specific pathways and downstream targets remain to be elucidated. The first group of MAP kinases discovered to be activated by LPS stimulation in macrophages were members of the ERK family. 39 In general, activation of ERKs can occur via signaling from receptor tyrosine kinases, such as epidermal growth factor receptor (EGF) and platelet-derived growth factor receptor (PDGF), through activation of the G-protein Ras. Activated Ras interacts with Raf-1, leading to its recruitment to the plasma membrane, whereupon Raf-1 is phosphorylated by another kinase. Once activated, Raf-1 may phosphorylate MAP kinase kinase-1 (MKK-1, also known as MEK), which in turn phosphorylates ERK. Following treatment with the selective MEK inhibitor U0126, LPS-stimulated monocytes failed to release IL-1, IL-8, TNF-α, or PGE 2 , correlating with decreased mRNA levels. ERK is also not activated in response to treatment of macrophages from C3H/HeJ mice with LPS. 40 Dominant negative mutants of Ras or Raf-1 components of the ERK cascade can inhibit LPS-stimulated TNF-α production. 40, 41 Although up-regulation of Raf-1 has been shown to strongly activate ERK, it causes only a small increase in TNF-α production. 40, 41 This indicates that other signaling pathways likely act in synergy with the ERK cascade.
Both isoforms of JNK, JNK1 and JNK2, are activated in LPS-treated macrophages. 42 Activation of the JNK cascade by LPS is thought to occur in the following sequence: MEKK1 → MKK4 → JNK. However, the upstream elements of the JNK pathway in LPS-stimulated macrophages have not yet been elucidated.
Activation of the p38 cascade by LPS is thought to occur via the upstream kinase MKK3, while the more proximal components of the cascade in LPS signaling have not yet been reported. It is known that p38 pathways are crucial to LPS-stimulated cytokine production. Studies have demonstrated that specific inhibition of p38 with the compound SB203580 in monocytes prevents LPS-stimulated production of IL-1β and TNF-α. 37, 43 These studies have indicated that the decrease in cytokine production is secondary to translational control.
Simultaneous activation of the three MAP kinase pathways in LPS-stimulated cells appears to be an important mechanism by which LPS signaling events culminate in the transcription of a number of pro-inflammatory regulators of the immune response. One of the most studied targets of the MAP kinase signaling cascades is the transcription factor AP-1. The promoters of many inflammatory response genes have AP-1 binding sites, suggesting a role for MAP kinases in their regulation. 35 The AP-1 transcription factor consists of either heterodimers or homodimers of members of the Jun family (c-jun, JunB, JunD), or heterodimers of members of the Jun family and Fos family (c-fos, FosB, Fra-1, Fra-2). Regulation of AP-1 occurs either by induced transcription of c-jun and c-fos, or post-transcriptional modification of c-jun. Transcription of c-fos is dependent on three transcriptional control elements, the serum response element (SRE), cAMP-response element (CRE), and the sis-inducible element (SIE). 44, 45 The SRE element is constitutively bound to serum response factor (SRF) and ternary complex factor (TCF), which is composed of Elk-1, Sap-1a, or Sap2. Elk-1 can be phosphorylated in vitro by JNK, ERK, and p38; Sap-1a by ERK and p38. [45] [46] [47] The c-fos SIE is bound by a complex of the transcription factors STAT1 and STAT3, which is potentiated by serine phosphorylation, possibly by ERK (AP-1). The c-jun promoter is mediated by two transcription response elements, Jun1 and Jun2. These promoter elements are constitutively occupied and preferentially bind heterodimers of c-jun and ATF-2. c-jun and ATF-2 are each phosphorylated on two sites in their transcriptional activation domains by the JNK group of MAP kinases, leading to increased transcriptional activity. 48 In contrast, p38 MAP kinase phosphorylates and activates ATF-2 but not c-jun in response to similar stimuli. 34 Overall, AP-1 can act as a point of integration of all three MAP kinase pathways.
Taken together, all of these elements demonstrate clearly that HC are capable of and indeed do respond to microbial products. Because of the importance of CD14, TLR2, and TLR4 in the cellular responses to bacteria, we undertook a detailed characterization of these receptors in HC. Our results demonstrate that hepatocytes are responsive either to LPS directly or to the cytokines produced in response to LPS, and suggest an important role for these cells in the response to bacterial infection.
MATERIALS AND METHODS
Reagents
LPS (Escherichia coli 0111:B4) was purchased from Sigma Chemical Company (St Louis, MO, USA). Recombinant murine IL-1β and TNF-α were a kind gift from Dr Craig Reynolds (National Cancer Institute, Bethesda, MD, USA). IL-1 receptor antagonist protein (IL-1ra) and TNF-α receptor I antagonist protein (polyethleneglycol-linked dimer of type I soluble TNF-α receptor, sTNF-RI) were kindly provided by Dr James L. Vannice (Synergen Inc., Boulder, CO, USA).
Animals
Male Sprague-Dawley rats weighing approximately 200 g each and pathogen-free were purchased from Harlan Sprague Dawley (Indianapolis, IN, USA) . The animals were injected with LPS as described. 25, 26, 31 Experimental protocols were approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh.
Hepatocyte isolation and cell culture
Hepatocytes were isolated from male pathogen-free Sprague-Dawley rats (Harlan Sprague-Dawley, Indianapolis IN) by an in situ collagenase (type VI; Sigma) perfusion technique. 26, 31 
Characterization of basal transcription of CD14 in hepatocytes
Isolation of nuclei, in vitro labeling of nascent nuclear RNA, and hybridization were performed using published protocols. 25 Analysis of promoter deletion constructs linked to the luciferase reporter gene, as well as electromobility shift and supershift assays, were performed as described in detail elsewhere. 26 
RESULTS AND DISCUSSION
Molecular regulation of the basal expression of CD14 by hepatocytes
Based on the importance of soluble CD14 to the systemic response to infection and the potential importance of hepatic CD14 to LPS-liver interactions, we undertook a study to determine the factors that govern basal CD14 gene expression in hepatocytes. 26 In order to carry out this analysis, we had to first clone the rat CD14 gene by screening a rat genomic library. Of 10 6 phages screened, four positive recombinant phages were identified. One clone contained the entire rat CD14 gene as determined by further restriction mapping, releasing a 1.4 kb fragment. Several putative Sp1 regulatory motifs were identified. Two tandem putative Sp1 elements are located at positions -873 and -866 with respect to the transcription start site. Another three Sp1 motifs are located at -836, -401, and -121, respectively. An AP-1/CRE and an AP-1 regulatory motif are located at -551 and -270, respectively. The TATA box is located at -47. The transcription start site in rat CD14 gene was determined using the primer extension assay. It was determined that the transcription start site was located at the adenine site, which is 93 bp upstream of the ATG translation start codon and 39 bp downstream from the TATA-like element. 26 Our data 26 clearly indicate that liver cells have a relatively high basal CD14 transcription rate as compared even to myeloid-derived cells. Deletional analysis and subsequently site-directed mutagenesis/deletional analysis using promoter-luciferase constructs in H4-II-E-C3 and primary rat hepatocytes identified the functional effects and significance of trans-acting factors (Sp1, Sp3, Fra-2, and JunD) in the control of basal transcription of CD14, and these results were confirmed by electromobility shift and supershift assays. 26 In our initial studies, we focused on the positive regulatory elements in the rat CD14 promoter and only characterized two important enhancer elements (-836 Sp1 and -270 AP-1). Our promoter deletion analysis suggests that other potential negative and positive regulatory elements could also exist within -464 to -339 and -399 to -277 regions, respectively. Deletion downstream to base -237 reduced the promoter activity to basal level, indicating that the AP-1 motif located at -270 might be a critical element in supporting CD14 expression in liver cells. 26 Taken together, these studies represent the first detailed molecular characterization of the basal transcription of CD14 in hepatocytes, and strongly suggest a co-ordinated regulatory mechanism.
Role of cytokines in induction of rat TLR2 gene expression by LPS
Our initial foray into the molecular characterization of the response of hepatocytes to microbial products involved the cloning and promoter analysis of the rat hepatocyte CD14 as described above. We next sought to examine the expression of receptors associated with responses to Gram-positive bacteria. Accordingly, we sought to determine the factors that govern the expression of TLR2 in the liver, both in vivo and in vitro. 31 We initially tested the hypothesis that LPS could increase the expression of TLR2 in vivo. Rats were injected with either LPS or saline, and, after 6 h, total RNA was extracted and assayed for the presence of TLR2 mRNA by Northern blotting. This analysis demonstrated that LPS treatment significantly increased the TLR2 mRNA levels in all tissues examined. The highest expression was elicited in liver, followed by the lung and spleen.
To determine the role of mRNA transcription in the large increase in hepatic TLR2 expression by LPS in vivo, we carried out a nuclear run-on assay on total liver cells of normal and LPS-treated rats. Increased transcription rates for TLR2 were observed at 3 h in total liver cells from LPS-treated rats. At 6 h after LPS treatment, the transcription of TLR2 had decreased; at 24 h, the transcription rates returned almost to basal level. Thus, the up-regulation of hepatic TLR2 mRNA levels during endotoxemia involves increased transcription. 31 We next examined the expression of TLR2 in vitro, in isolated rat hepatocytes. Intriguingly, LPS alone did not induce expression of TLR2; 31 accordingly, we set out to determine whether pro-inflammatory cytokines known to be induced by LPS modulated TLR2 in hepatocytes in vitro. We found that treatment with IL-1β significantly increased the levels of TLR2 mRNA: by 6 h following treatment with IL-1β, the increase in TLR2 expression was 8.3-fold (P <0.05), whereas maximal induction was observed after 12-24 h of treatment. IL-1β combined with TNF-α caused a greater increase in TLR2 mRNA accumulation (11.8-fold increase at 6 h) than that of IL-1β alone. 31 To establish the involvement of IL-1 and/or TNF-α in the up-regulation of hepatic TLR2 in vivo, experiments were carried out using IL-1 receptor antagonist (IL-1ra) and soluble TNF-α receptor I (sTNF-RI) to block action of IL-1 or TNF-α, respectively. Rats were treated with LPS alone or LPS + IL-1ra, sTNF-RI, or both in vivo for 6 h, and Northern blot analysis was performed to determine the levels of hepatic TLR2 mRNA levels. We observed that LPS significantly up-regulated hepatic TLR2 mRNA levels (P <0.05). Compared to rats given LPS alone, rats treated with LPS + IL-1ra or LPS + sTNF-RI exhibited a 37.5% and 32.5% decrease (P <0.05) in hepatic TLR2 mRNA levels, respectively. This finding implicates IL-1 and TNF-α in the up-regulation of hepatic TLR2 mRNA in vivo and accords with our in vitro studies. Finally, we determined that IL-1β does not affect the half-life of TLR2 mRNA significantly. 31 These results suggest that there might be an interplay among the cell types present in the liver (hepatocytes, Kupffer cells, stellate cells, and sinusoidal endothelial cells) with regard to the induction of TLR2, with one cell type sensing LPS directly (presumably through TLR4) and then leading to release of cytokines such as IL-1β and TNF-α.
CONCLUSIONS
Recent studies from our laboratory and those of others are giving credence to the assertion that hepatocytes are clearly capable of responding to microbial products, either directly or indirectly through responses to proinflammatory cytokines. The basal expression of CD14 in hepatocytes could represent an innate immune response against the infection by micro-organisms, by promoting the clearance of micro-organisms or their products. Thus, it is conceivable that common regulatory transcription factors such as Sp1, Fra-2, and JunD are critical in controlling an adequate basal level of CD14 expression in liver cells. This expression would maintain adequate levels of CD14 surface expression on hepatocytes and circulate soluble CD14 through the on-going synthesis of CD14 by hepatocytes.
Likewise, the induction of TLR2 in hepatocytes by the TLR4-ligand LPS may further increase the potency of a response to polymicrobial infections by increasing sensitivity to Gram-positive stimulants. A likely scenario for this would involve the production of IL-1β and TNF-α by TLR4-expressing Kupffer cells, which in turn would act to stimulate TLR2 on hepatocytes (Fig. 3) . Another, more speculative, possibility is that TLR2 is up-regulated in order to assist in the clearance of LPS as opposed to direct signaling. We base this speculation on the much lower affinity of LPS for TLR2 versus TLR4. 6, 49 As seen in Table 1 , little or nothing is known about the responses of isolated hepatocytes or Kupffer cells to the Gram-positive products. Clearly, further studies are needed to define the mechanisms by which the expression of CD14 is further induced in hepatocytes, 25 as well as to determine the functional significance of TLR2 in hepatocytes. 3 Possible intracellular interactions to induce TLR2 on hepatocytes. Following binding of LPS or Gram-positive bacterial products to LBP and subsequently to CD14, the complex signals intracellularly through Tolllike receptor 4 (TLR4) on Kupffer cells (KC). This leads to the production of TNF-α and IL-1β by the Kupffer cells, and these cytokines in turn induce TLR2 on hepatocytes (HC).
